1-12 of 12
J. Wolf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Report from a Multicenter Trial of Perifosine (KRX-0401) + Bortezomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma Previously Treated with Bortezomib.

Paul Richardson, A. Jakubowiak, J. Wolf, J. Allerton, J. Zonder, S. Lonial, A. Krishnan, J. Densmore, I. Ghobrial, K. Colson, T. Kendall, C. Leister, B. Martineau, T. Hideshima, T. Facon, P. Sportelli, L. Gardner, R. Birch, I.C. Henderson, K. Anderson
Journal: Blood
Blood (2007) 110 (11): 1170.
https://doi.org/10.1182/blood.V110.11.1170.1170
Published: 2007
Journal Articles

Multi-Center Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Promising Activity as Combination Therapy with Manageable Toxicity.

Paul Richardson, S. Lonial, A. Jakubowiak, A. Krishnan, J. Wolf, J. Densmore, S. Singhal, I. Ghobrial, J. Stephenson, J. Mehta, K. Colson, D. Francis, T. Kendall, N. Obadike, K. Sullivan, J. Martin, T. Hideshima, L. Lai, P. Sportelli, L. Gardner, R. Birch, I.C. Henderson, K. Anderson
Journal: Blood
Blood (2007) 110 (11): 1164.
https://doi.org/10.1182/blood.V110.11.1164.1164
Published: 2007
Journal Articles

A Multicenter Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (Dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM).

Paul Richardson, S. Lonial, A. Jakubowiak, J. Wolf, A. Krishnan, J. Densmore, S. Singhal, I. Ghobrial, L. Schwartzberg, K. Colson, J. Harris, T. Kendall, B. Martineau, N. Obadike, K. Sullivan, S. Pearson, T. Hideshima, L. Lai, P. Sportelli, L. Gardner, R. Birch, I.C. Henderson, K.C. Anderson
Journal: Blood
Blood (2006) 108 (11): 3582.
https://doi.org/10.1182/blood.V108.11.3582.3582
Published: 2006
Journal Articles

Bortezomib Therapy Alone and in Combination with Dexamethasone for Patients with Previously Untreated Multiple Myeloma.

Sundar Jagannath, B. Durie, J. Wolf, E. Camacho, D. Irwin, J. Lutzky, M. McKinley, E. Gabayan, A. Mazumder, J. Crowley, R. Vescio, D. Schenkein
Journal: Blood
Blood (2005) 106 (11): 783.
https://doi.org/10.1182/blood.V106.11.783.783
Published: 2005
Journal Articles

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller-Hermelink, R. Herrmann, B. Doerken, L. Kanz, R. Greil, B. Pfistner, for the German Hodgkin′s lymphoma study group (GHSG), the Competence Network Malignant Lymphoma.
Journal: Blood
Blood (2004) 104 (11): 1307.
https://doi.org/10.1182/blood.V104.11.1307.1307
Published: 2004
Journal Articles

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller Hermelink, R. Herrman, J. Markova, A. Ho, W. Hiddemann, B. Doerken, R. Greil, B. Pfistner, for the German Hodgkin′s Lymphoma Study Group (GHSG), the Competence Network Malignant Lymphoma.
Journal: Blood
Blood (2004) 104 (11): 1308.
https://doi.org/10.1182/blood.V104.11.1308.1308
Published: 2004
Journal Articles

Comprehensive cytogenetic and molecular genetic characterization of the TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell line

Laura J. Rush, Kristiina Heinonen, Krzysztof Mrózek, Bryan J. Wolf, Mohamed Abdel-Rahman, Jadwiga Szymanska, Paivi Peltomäki, Fehmida Kapadia, Clara D. Bloomfield, Michael A. Caligiuri, Christoph Plass
Journal: Blood
Blood (2002) 99 (5): 1874–1876.
https://doi.org/10.1182/blood.V99.5.1874
Published: 2002
Journal Articles

Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells

J Wolf, U Kapp, H Bohlen, M Kornacker, C Schoch, B Stahl, S Mucke, C von Kalle, C Fonatsch, HE Schaefer, ML Hansmann, V Diehl
Journal: Blood
Blood (1996) 87 (8): 3418–3428.
https://doi.org/10.1182/blood.V87.8.3418.bloodjournal8783418
Published: 1996
Journal Articles

Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed- Sternberg cells of a Hodgkin's lymphoma patient

H Kanzler, ML Hansmann, U Kapp, J Wolf, V Diehl, K Rajewsky, R Kuppers
Journal: Blood
Blood (1996) 87 (8): 3429–3436.
https://doi.org/10.1182/blood.V87.8.3429.bloodjournal8783429
Published: 1996
Journal Articles

Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins

U Winkler, C Gottstein, G Schon, U Kapp, J Wolf, ML Hansmann, H Bohlen, P Thorpe, V Diehl, A Engert
Journal: Blood
Blood (1994) 83 (2): 466–475.
https://doi.org/10.1182/blood.V83.2.466.466
Published: 1994
Journal Articles

Hodgkin's lymphoma-derived tissue serially transplanted into severe combined immunodeficient mice

U Kapp, J Wolf, M Hummel, M Pawlita, C von Kalle, F Dallenbach, M Schwonzen, GR Krueger, N Muller-Lantzsch, C Fonatsch
Journal: Blood
Blood (1993) 82 (4): 1247–1256.
https://doi.org/10.1182/blood.V82.4.1247.1247
Published: 1993
Journal Articles

Inhibition of erythropoietin production in unanesthetized rabbits exposed to an acute hypoxic-hypercapnic environment

J Wolf-Priessnitz, JC Schooley, LJ Mahlmann
Journal: Blood
Blood (1978) 52 (1): 153–162.
https://doi.org/10.1182/blood.V52.1.153.153
Published: 1978